Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 111 | Accofil | Authorised | filgrastim | Accord Healthcare S.L.U. | 25-05-2018 | |
| 112 | Pyzchiva | Authorised | ustekinumab | Crohn Disease;Colitis, Ulcerative;Arthritis, Psoriatic | Samsung Bioepis NL B.V. | 23-02-2024 |
| 113 | Eiyzey | Authorised | aflibercept | Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A. | 20-06-2025 |
| 114 | Gobivaz | Authorised | golimumab | Arthritis, Rheumatoid;Arthritis, Juvenile;Arthritis, Psoriatic;Axial Spondyloarthritis;Colitis, Ulcerative;Non-Radiographic Axial Spondyloarthritis | Advanz Pharma Limited | 19-09-2025 |
| 115 | Ranivisio | Authorised | ranibizumab | Wet Macular Degeneration;Macular Edema;Diabetic Retinopathy;Diabetes Complications | Midas Pharma GmbH | 20-06-2022 |
| 116 | Epruvy (previously Ranibizumab Midas) | Authorised | ranibizumab | Wet Macular Degeneration;Macular Edema;Choroidal Neovascularization;Diabetes Complications | Midas Pharma GmbH | 26-07-2024 |
| 117 | Eyluxvi | Authorised | aflibercept | Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion | Biolitec pharma Limited Zweigniederlassung Jena | 25-07-2025 |
| 118 | Flixabi | Authorised | infliximab | Arthritis, Psoriatic;Spondylitis, Ankylosing;Colitis, Ulcerative;Arthritis, Rheumatoid;Crohn Disease;Psoriasis | Samsung Bioepis NL B.V. | 06-08-2018 |
| 119 | Baiama | Authorised | aflibercept | Wet Macular Degeneration;Macular Edema;Retinal Vein Occlusion;Choroidal Neovascularization;Diabetes Complications | Formycon AG | 11-11-2024 |
| 120 | Ahzantive | Authorised | aflibercept | Wet Macular Degeneration;Macular Edema;Retinal Vein Occlusion;Choroidal Neovascularization;Diabetes Complications | Formycon AG | 15-11-2024 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.